FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nils Egberg

Research Profile

Concepts & Ideas

Physiology

Blood Coagulation

Anatomy

Blood Platelets

Chemicals & Drugs

Phenomena

Prothrombin Time

Procedures

Geographic Areas

Sweden

Co-author Network

Publications

TOP 3
Fariborz Mobarrez; Jovan P Antovic; Nils Egberg; Mona Hansson; Gun Jörneskog; Kjell Hultenby; Håkan Wallén
A multicolor flow cytometric assay for measurement of platelet-derived microparticles.
Shu He; Kun Zhu; Mika Skeppholm; Jenny Vedin; Jan Svensson; Nils Egberg; Margareta Blombäck; Håkan N Wallen
A global assay of haemostasis which uses recombinant tissue factor and tissue-type plasminogen activator to measure the rate of fibrin formation and fibrin degradation in plasma.
F Boström; M Sjödahl; Lena Wehlin; Nils Egberg; Joachim Lundahl
Coagulation parameters in apheresis and leukodepleted whole-blood plasma during storage.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nils Egberg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Fariborz Mobarrez; Jovan P Antovic; Nils Egberg; Mona Hansson; Gun Jörneskog; Kjell Hultenby; Håkan Wallén
A multicolor flow cytometric assay for measurement of platelet-derived microparticles.
Thrombosis research 2010;125(3):e110-6.
2007: Shu He; Kun Zhu; Mika Skeppholm; Jenny Vedin; Jan Svensson; Nils Egberg; Margareta Blombäck; Håkan N Wallen
A global assay of haemostasis which uses recombinant tissue factor and tissue-type plasminogen activator to measure the rate of fibrin formation and fibrin degradation in plasma.
Thrombosis and haemostasis 2007;98(4):871-82.
2007: F Boström; M Sjödahl; Lena Wehlin; Nils Egberg; Joachim Lundahl
Coagulation parameters in apheresis and leukodepleted whole-blood plasma during storage.
Transfusion 2007;47(3):460-3.
2007: Dag Nilsson; Johan Wemer; Yi-Fang Cheng; Ingalill Reinholdsson; Gunnar Englund; Nils Egberg; Sam Schulman
NXY-059 does not affect bleeding time in healthy volunteers: a randomized, double-blind, placebo-controlled, 3-period crossover phase I study.
Journal of clinical pharmacology 2007;47(2):264-72.
2006: Carl-Magnus Wahlgren; Margareta Sten-Linder; Nils Egberg; Bo Kalin; L Blohmé; Jesper Swedenborg
The role of coagulation and inflammation after angioplasty in patients with peripheral arterial disease.
Cardiovascular and interventional radiology 2006;29(4):530-5.
2006: Lena Carlsson; Gunnar Ronquist; Rune Eliasson; Nils Egberg; Anders Larsson
Flow cytometric technique for determination of prostasomal quantity, size and expression of CD10, CD13, CD26 and CD59 in human seminal plasma.
International journal of andrology 2006;29(2):331-8.
2005: Nils Egberg; Inger Fagerberg; Andreas Hillarp; Tomas L Lindahl; Lennart Stigendal
Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination--a rebuttal.
Journal of thrombosis and haemostasis : JTH 2005;3(10):2370-1; author reply 2731-2.
2004: Andreia Bunescu; Peter Seideman; Rodica Lenkei; Klas Levin; Nils Egberg
Enhanced Fcgamma receptor I, alphaMbeta2 integrin receptor expression by monocytes and neutrophils in rheumatoid arthritis: interaction with platelets.
The Journal of rheumatology 2004;31(12):2347-55.
2004: Tomas L Lindahl; Nils Egberg; Andreas Hillarp; Ole Rasmus Ødegaard; Bror Edlund; Jan Svensson; Per Morten Sandset; Mats Rånby
INR calibration of Owren-type prothrombin time based on the relationship between PT% and INR utilizing normal plasma samples.
Thrombosis and haemostasis 2004;91(6):1223-31.
2004: Andreas Hillarp; Nils Egberg; Gunnar Nordin; Lennart Stigendal; Inger Fagerberg; Tomas L Lindahl
Local INR calibration of the Owren type prothrombin assay greatly improves the intra- and interlaboratory variation. A three-year follow-up from the Swedish national external quality assessment scheme.
Thrombosis and haemostasis 2004;91(2):300-7.
2003: Anders Kallner; Nils Egberg; Anna Yu; Rumjana Merzoug-Djilali; Inger Blomberg; Gun Jörneskog; Margareta Blombäck
Are results of fibrinogen measurements transferable?
Clinical chemistry and laboratory medicine : CCLM / FESCC 2003;41(6):804-8.
2003: A Yu; Nils Egberg; Stefan H Jacobson
Haemostatic complications in haemodialysis patients: effect of type of vascular access and dialysis filter.
Scandinavian journal of clinical and laboratory investigation 2003;63(2):127-33.
2002: Andreas Hillarp; Nils Egberg; Inger Fagerberg; Tomas L Lindahl; Gunnar Nordin; Lennart Stigendal
[Less variation in laboratory results after the introduction of INR. Differences between hospital laboratories and laboratories within primary health care are levelled out].
Läkartidningen 2002;99(50):5068-70, 5073-4.
2002: Margita Eriksson-Berg; Nils Egberg; Staffan Eksborg; Karin Schenck-Gustafsson
Retained fibrinolytic response and no coagulation activation after acute physical exercise in middle-aged women with previous myocardial infarction.
Thrombosis research 2002;105(6):481-6.
2002: Johanna S Ungerstedt; Sam Schulman; Nils Egberg; Jovan P Antovic; Nargareta Blombäck
Discrepancy between antithrombin activity methods revealed in Antithrombin Stockholm: do factor Xa-based methods overestimate antithrombin activity in some patients?
Blood 2002;99(6):2271-2.
2002: Andreia Bunescu; J Widman; Rodica Lenkei; P Menyes; K Levin; Nils Egberg
Increases in circulating levels of monocyte-platelet and neutrophil-platelet complexes following hip arthroplasty.
Clinical science (London, England : 1979) 2002;102(3):279-86.
2002: Stefan H Jacobson; Nils Egberg; Britta Hylander; Joachim Lundahl
Correlation between soluble markers of endothelial dysfunction in patients with renal failure.
American journal of nephrology 2002;22(1):42-7.
2002: Anna Yu; Stefan H Jacobson; Anette Bygdén; Nils Egberg
The presence of heparin-platelet factor 4 antibodies as a marker of hypercoagulability during hemodialysis.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2002;40(1):21-6.
2001: P Ridefelt; Nils Egberg; Andreas Hillarp; Stefan Lethagen; Lilian Tengborn
[New in vitro analysis tested: bleeding time is still the best method for evaluation of primary hemostasis].
Läkartidningen 2001;98(37):3922-4.
2001: Andreia Bunescu; M Hild; Joachim Lundahl; Nils Egberg
Platelet storage in PAS-2 or autologous plasma: impact on functional parameters.
Transfusion medicine (Oxford, England) 2001;11(2):105-10.
1999: Rikard Linder; Margareta Blombäck; Nils Egberg; Lars Grip
Thrombin inhibitors suppress the thrombin-thrombomodulin-mediated generation of activated protein C.
Thrombosis research 1999;95(2):117-25.
1999: Nils Egberg; Andreas Hillarp; H Johnsson; T Lindahl; Lennart Stigendal
[Coordinated Swedish transfer is recommended during 1999. Prothrombin complex measurement should be indicated as a quota, not percent].
Läkartidningen 1999;96(20):2489-91.
1999: P Lindmarker; Sam Schulman; Margareta Sten-Linder; Björn Wiman; Nils Egberg; H Johnsson
The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene. DURAC Trial Study Group. Duration of Anticoagulation.
Thrombosis and haemostasis 1999;81(5):684-9.
1999: Rikard Linder; Jonas Oldgren; Nils Egberg; Lars Grip; G Larson; Agneta Siegbahn; Lars Wallentin
The effect of a low molecular mass thrombin inhibitor, inogatran, and heparin on thrombin generation and fibrin turnover in patients with unstable coronary artery disease.
European heart journal 1999;20(7):506-18.
1999: M Eriksson; Nils Egberg; Sarah P Wamala; Kristina Orth-Gomér; Murray A Mittleman; Karin Schenck-Gustafsson
Relationship between plasma fibrinogen and coronary heart disease in women.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(1):67-72.
1998: M Hild; T Söderström; Nils Egberg; Joachim Lundahl
Kinetics of bradykinin levels during and after leucocyte filtration of platelet concentrates.
Vox sanguinis 1998;75(1):18-25.
1997: Lars Grip; Margareta Blombäck; Nils Egberg; A Olsson; Bertil Svane; M Velander
Antithrombin III supplementation for patients undergoing PTCA for unstable angina pectoris. A controlled randomized double-blind pilot study.
European heart journal 1997;18(3):443-9.